University of Utah Research Foundation

Technion Research & Development Foundation Ltd

Ballard Spahr Llp

Joshua Schiffman

Avi Schroeder

Guy A Zimmerman

Christian Con Yost

Andrew S Weyrich

Lisa Abegglen

The present disclosure is directed to methods and compositions for inhibiting a cancer cell using nucleic acid sequences encoding elephant p53 or elephant p53 amino acid sequences.

Methods and compositions for preventing or treating cancer

Neonatal NET-inhibitory Factor (nNIF) and nNIF-Related Peptides (NRPs) are provided. Methods for the treatment of and prophylaxis against inflammatory disorders and cancer are also provided. Additionally, methods for the inhibition of metastasis in patients having cancer are provided. The methods can include administering nNIF and/or a NRP to patients having, or at risk of developing, an inflammatory disorder or a cancer.

NNIF and nNIF-related peptides and related methods

Neonatal NET-Inhibitory Factor (nNIF) and nNIF-Related Peptides (NRPs) are provided. Methods for the treatment of and prophylaxis against inflammatory disorders and cancer are also provided. Additionally, methods for the inhibition of metastasis in patients having cancer are provided. The methods can include administering nNIF and/or a NRP to patients having, or at risk of developing, an inflammatory disorder or a cancer.

Growing community of inventors

Salt Lake City, UT, United States of America

Joshua Schiffman